News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
175,444 Results
Type
Article (31948)
Company Profile (12)
Press Release (143484)
Multimedia
Podcasts (9)
Webinars (10)
Section
Business (51952)
Career Advice (364)
Deals (3218)
Drug Delivery (11)
Drug Development (23828)
Employer Resources (32)
FDA (3347)
Job Trends (3177)
News (80345)
Policy (4200)
Tag
Academia (2409)
Academic (1)
Accelerated approval (6)
Adcomms (9)
Allergies (35)
Alliances (10850)
ALS (47)
Alzheimer's disease (599)
Antibody-drug conjugate (ADC) (45)
Approvals (3446)
Artificial intelligence (112)
Autoimmune disease (28)
Automation (7)
Bankruptcy (17)
Best Places to Work (2653)
BIOSECURE Act (3)
Biosimilars (13)
Biotechnology (12)
Bladder cancer (36)
Brain cancer (26)
Breast cancer (180)
Cancer (1313)
Cardiovascular disease (90)
Career advice (341)
Career pathing (9)
CAR-T (77)
CDC (19)
Cell therapy (191)
Cervical cancer (9)
Clinical research (19521)
Collaboration (315)
Company closure (1)
Compensation (22)
Complete response letters (6)
COVID-19 (1204)
CRISPR (28)
C-suite (530)
Cystic fibrosis (32)
Data (2005)
Decentralized trials (1)
Denatured (6)
Depression (36)
Diabetes (119)
Diagnostics (1726)
Digital health (4)
Diversity (6)
Diversity, equity & inclusion (13)
Drug discovery (49)
Drug pricing (13)
Drug shortages (2)
Duchenne muscular dystrophy (40)
Earnings (6545)
Editorial (8)
Employer branding (2)
Employer resources (30)
Events (18430)
Executive appointments (619)
FDA (3906)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (5)
Funding (388)
Gene editing (58)
Generative AI (5)
Gene therapy (132)
GLP-1 (163)
Government (989)
Guidances (24)
Healthcare (5036)
HIV (14)
Huntington's disease (6)
IgA nephropathy (24)
Immunology and inflammation (22)
Immuno-oncology (12)
Indications (19)
Infectious disease (1268)
Inflammatory bowel disease (53)
Inflation Reduction Act (1)
Influenza (36)
Intellectual property (36)
Interviews (41)
IPO (1457)
IRA (8)
Job creations (581)
Job search strategy (316)
JPM (4)
Kidney cancer (7)
Labor market (16)
Layoffs (38)
Leadership (5)
Legal (685)
Liver cancer (26)
Longevity (2)
Lung cancer (148)
Lymphoma (120)
Machine learning (10)
Management (9)
Manufacturing (94)
MASH (59)
Medical device (3114)
Medtech (3124)
Mergers & acquisitions (1850)
Metabolic disorders (248)
Multiple sclerosis (37)
NASH (5)
Neurodegenerative disease (91)
Neuropsychiatric disorders (11)
Neuroscience (913)
Neurotech (1)
NextGen: Class of 2026 (1792)
Non-profit (1711)
Now hiring (6)
Obesity (64)
Opinion (37)
Ovarian cancer (62)
Pain (40)
Pancreatic cancer (71)
Parkinson's disease (84)
Partnered (6)
Patents (68)
Patient recruitment (131)
Peanut (14)
People (33251)
Phase 1 (6169)
Phase 2 (8940)
Phase 3 (5977)
Pipeline (869)
Policy (51)
Postmarket research (956)
Preclinical (3151)
Press Release (25)
Prostate cancer (68)
Psychedelics (10)
Radiopharmaceuticals (75)
Rare diseases (173)
Real estate (1288)
Recruiting (16)
Regulatory (3350)
Reports (4)
Research institute (1380)
Resumes & cover letters (23)
Rett syndrome (4)
RNA editing (3)
RSV (5)
Schizophrenia (29)
Series A (59)
Series B (31)
Sickle cell disease (27)
Spinal muscular atrophy (43)
Sponsored (7)
Startups (1114)
Stomach cancer (1)
Supply chain (1)
Tariffs (7)
The Weekly (3)
Vaccines (277)
Venture capital (12)
Weight loss (37)
Women's health (20)
Worklife (2)
Date
Last 7 days (96)
Last 30 days (392)
Last 365 days (6170)
2026 (527)
2025 (6292)
2024 (7444)
2023 (9210)
2022 (11470)
2021 (13220)
2020 (12738)
2019 (12100)
2018 (8976)
2017 (8674)
2016 (8868)
2015 (10195)
2014 (7786)
2013 (7564)
2012 (7525)
2011 (7534)
2010 (6758)
Location
Africa (262)
Alabama (15)
Alaska (3)
Arizona (53)
Arkansas (6)
Asia (10693)
Australia (2666)
California (2348)
Canada (663)
China (244)
Colorado (100)
Connecticut (89)
Delaware (61)
Europe (28432)
Florida (296)
Georgia (83)
Idaho (13)
Illinois (182)
India (6)
Indiana (92)
Iowa (9)
Japan (107)
Kansas (19)
Kentucky (6)
Louisiana (7)
Maine (16)
Maryland (265)
Massachusetts (1574)
Michigan (52)
Minnesota (110)
Mississippi (4)
Missouri (36)
Montana (6)
Nebraska (5)
Nevada (20)
New Hampshire (12)
New Jersey (642)
New Mexico (8)
New York (657)
North Carolina (365)
North Dakota (3)
Northern California (1222)
Ohio (99)
Oklahoma (8)
Oregon (9)
Pennsylvania (447)
Puerto Rico (4)
Rhode Island (15)
South America (289)
South Carolina (11)
Southern California (863)
Tennessee (46)
Texas (387)
United States (8237)
Utah (71)
Virginia (56)
Washington D.C. (19)
Washington State (201)
West Virginia (2)
Wisconsin (26)
175,444 Results for "mcmaster university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Stoked Bio Licenses Global Rights for Novel Antibiotic from McMaster University
Enterololin uses a novel mechanism of action to attack the infection. New treatment has potential use in Crohn’s Disease. License is under existing Research and Collaboration Agreement with McMaster.
December 4, 2025
·
3 min read
Bio NC
Pfizer invests $4.9M in McMaster University study to help improve care for multiple myeloma patients in Canada
Pfizer is proud to announce that it is supporting a McMaster University-led study, through the Ontario Clinical Oncology Group, that aims to improve care for Canadians living with multiple myeloma.
June 3, 2024
·
5 min read
Business
Fuzionaire Diagnostics Enters Agreement with McMaster University to Expand Capabilities in Developing Theranostic Radiopharmaceuticals
Fuzionaire Diagnostics, Inc. (“Fuzionaire Dx”) today announced a collaborative research agreement with McMaster University (“McMaster”) under which theranostic radiopharmaceuticals developed with Fuzionaire Dx’s HetSiFA® platform will be evaluated at McMaster’s comprehensive preclinical nuclear medicine facilities.
June 29, 2022
·
2 min read
Ceapro Inc. Presents Encouraging Results from Research Collaboration Study with McMaster University Evaluating PGX-Processed Yeast Beta Glucan for Interstitial Lung Diseases
Ceapro Inc. (TSX-V: CZO; OTCQX:CRPOF) (“Ceapro” or the “Company”) today announced encouraging results from it’s completed pre-clinical CHRP study conducted with McMaster University evaluating PGX-processed yeast beta glucan (PGX-YBG) as a potential therapeutic option for individuals suffering from interstitial lung diseases (ILD).
May 23, 2023
·
7 min read
Press Releases
Hemostemix Presents ACP-01 Data at University of Florida Grand Rounds: Highlights Strong Safety, Functional Gains, and Florida Access Pathway
Session led by neurosurgeon Dr. Fraser Henderson and Hemostemix CEO Thomas Smeenk for the University of Florida’s Department of Surgery, Division of Vascular Surgery & Endovascular Therapy (Gainesville)
November 13, 2025
·
10 min read
Rapid Dose Therapeutics and McMaster University’s COVID-19 Vaccine Study Receives NSERC Research and Development Grant
Today, Rapid Dose Therapeutics Corp. (“ RDT ” or the “ Company ”) ( CSE: DOSE ) and McMaster University (“ McMaster ”) are pleased to announce that the ongoing development of an orally delivered vaccine candidate for COVID-19 has received the final installment of the Collaborative Research and Development grant, with a value of $120,000, from the Natural Sciences and Engineering Research Council of Canada (NSERC).
December 22, 2021
·
3 min read
Press Releases
University of Phoenix appoints Sheila Babendir as Dean of the College of Social and Behavioral Sciences
January 21, 2026
·
3 min read
Ceapro Inc. Expands Collaborative Research Program with McMaster University to Develop an Inhalable Immuno-Therapeutic/-Prophylactic for COVID-19-Induced Lung Fibrosis
Ceapro Inc. (TSX-V: CZO; OTCQX:CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced it has entered into an additional research project expanding on the ongoing collaboration with McMaster University to develop an inhalable immuno-therapeutic/-prophylactic for COVID-19-induced lung fibrosis.
August 11, 2022
·
6 min read
Rapid Dose Therapeutics and McMaster University Provide COVID-19 Vaccine Research Update Including Significant Achievement of Milestones
Today, Rapid Dose Therapeutics Corp. (“ RDT ” or the “ Company ”) ( CSE: DOSE ) and McMaster University (“ McMaster ”) are reporting a preliminary, yet significant milestone in the investigation of an orally delivered vaccine candidate for COVID-19.
September 15, 2021
·
5 min read
Press Releases
Tolmar Opens Northern Illinois Laboratory at Rosalind Franklin University’s Innovation and Research Park
December 16, 2025
·
1 min read
1 of 17,545
Next